NCT02192749View on ClinicalTrials.gov

Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Autism
Interventions
BIOLOGICAL

Umbilical cord mesenchymal stem cells

Trial Locations (1)

Unknown

Stem Cell Institute, Panama City

All Listed Sponsors
lead

Translational Biosciences

INDUSTRY

NCT02192749 - Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism | Biotech Hunter | Biotech Hunter